Catalyst Biosciences

$4.94
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.06 (-1.17%) Today
-$0.11 (-2.18%) As of 8:27 PM UTC after-hours

Why Robinhood?

You can buy or sell CBIO and other stocks, options, and ETFs commission-free!

About CBIO

Catalyst Biosciences, Inc. Common Stock, also called Catalyst Biosciences, is a clinical-stage biopharmaceutical company.

CEO
Nassim Usman
Employees
56
Headquarters
South San Francisco, California
Founded
1997
Market Cap
155.47M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
259.30K
High Today
$5.13
Low Today
$5.01
Open Price
$5.08
Volume
196.53K
52 Week High
$8.22
52 Week Low
$4.05

CBIO Earnings

-$1.23
-$0.82
-$0.41
$0.00
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Estimated
— per share
Actual
Expected May 6, Pre-Market

You May Also Like

AVCTW
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure